"id:ID","instanceType","text","uuid","id","description","label","name"
"758","OBJECTIVE","To determine if there is a statistically significant relationship (overall Type 1 erroralpha=0.05) between the change in both the ADAS-Cog (11) and CIBIC+ scores, and drug dose (0, 50 cm2 [54 mg], and 75 cm2 [81 mg]).","b7dd7600-1542-406d-9658-a41c0e70b362","Objective_1","Main objective","","OBJ1"
"759","OBJECTIVE","To document the safety profile of the xanomeline TTS.","e290e498-e94f-49c4-ae4b-ce96e86f41e8","Objective_2","Safety","","OBJ2"
"760","OBJECTIVE","To assess the dose-dependent improvement in behavior. Improved scores on the Revised Neuropsychiatric Inventory (NPI-X) will indicate improvement in these
areas.","afb43737-c695-4e04-927d-e4065c1f7214","Objective_3","Behaviour","","OBJ3"
